Philips Slammed With $467M Verdict In Masimo Patent Trial
Law360, San Diego (October 1, 2014, 7:00 PM EDT) -- A Delaware federal jury on Wednesday awarded Masimo Corp. $466.7 million for Philips Electronics North America Corp.’s infringement of two patents for measuring blood oxygen levels, rejecting Philips’ arguments that the patents were invalid.
Philips had admitted it directly and indirectly infringed all of Masimo’s asserted claims, according to court documents, but argued the patents were not valid. But the jury ruled that Masimo’s patents were valid, finding they were not anticipated, indefinite, obvious, enabled or improperly written.
The jury also found that Philips had not proven Masimo literally or indirectly infringed Philips’ own patent for measuring medical signals.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!